Inactivating PSMB5 mutations and P-glycoprotein (MDR1/ ABCB1) mediate resistance to proteasome inhibitors: ex vivo efficacy of (immuno) proteasome inhibitors in mononuclear blood cells from rheumatoid arthritis patients

C.S.E. Verbrugge, Y.G. Assaraf, B.A.C. Dijkmans, G.L. Scheffer, M.C.M. Al, D. den Uyl, R. Oerlemans, E.T. Chan, C.J. Kirk, G.J. Peters, J.W. van der Heijden, T.D. de Gruijl, R.J. Scheper, G. Jansen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)174-182
JournalThe Journal of Pharmacology and Experimental Therapeutics
Issue number1
Publication statusPublished - 2012

Cite this